Since the last update on 31 May 2022, 384 monkeypox cases have been reported from 16 EU/EEA countries and 238 monkeypox cases have been reported from 8 non-EU/EEA countries.
As of 3 June 2022, 392 confirmed (n=370) and probable (n=22) cases of monophasic S. Typhimurium have been identified in the EU/EEA and the United Kingdom.
A multi-country outbreak of monkeypox is ongoing since early May. As of 25 May 2022, a total of 219 confirmed cases have been reported worldwide, with most of cases being detected in young men, self-identifying as men who have sex with men (MSM).
In a Rapid Risk Assessment published today, the European Centre for Disease Prevention and Control (ECDC) recommends EU/EEA countries focus on prompt identification, management, contact tracing and reporting of new monkeypox cases.
As of 16 May 2022, there is a multi-country outbreak of monkeypox affecting the UK, EU/EEA states, and North America. As of 20 May 2022, there have been a total of 36 confirmed cases reported worldwide.
On 18 May 2022, ECDC and EFSA published an update of the rapid outbreak assessment on a multi-country outbreak of monophasic Salmonella Typhimurium linked to chocolate products made at a factory in Arlon, Belgium.
As of 19 April 2022, an outbreak of 187 confirmed and probable cases of monophasic S. Typhimurium (cluster 1) has been identified in the EU/EEA and the United Kingdom.
On 12 April 2022, ECDC and EFSA published a rapid outbreak assessment on a multi-country outbreak of monophasic Salmonella Typhimurium linked to chocolate products made at a factory in Arlon, Belgium.